GlaxoSmithKline aims to make 1B doses of vaccine booster for multiple COVID-19 partners aliu Thu, 05/28/2020 – 09:04 More: GlaxoSmithKline aims to make 1B doses of vaccine booster for multiple COVID-19 partners Source: fierce
read moreLYT-100 employs a multimodal mechanism of action to potentially reduce, delay or prevent the lung dysfunction documented in COVID-19 patients More: PureTech advances experimental COVID-19 drug into global trials Source: News
read moreResearchers are hopeful that this ‘ground-breaking approach’ could accelerate the prediction of which patients are more at risk of their disease returning More: Researchers develop AI tool able to predict cancer relapse Source: News
read moreThe drug giant agreed a new price for Tecentriq with NHS England and Improvement More: NICE u-turn backs Roche's Tecentriq for small-cell lung cancer Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals